524602 — Bandaram Pharma Packtech Income Statement
0.000.00%
- IN₹436.32m
- IN₹638.36m
- IN₹369.64m
Annual income statement for Bandaram Pharma Packtech, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IAS | IAS | IAS | IAS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 0 | 187 | 341 | 370 |
Cost of Revenue | |||||
Gross Profit | 0 | 0 | 26.8 | 65.3 | 73.1 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 0.316 | 0.1 | 180 | 320 | 350 |
Operating Profit | -0.316 | -0.1 | 7.58 | 21.2 | 19.3 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -0.316 | -0.101 | 3.26 | 11.9 | 13.2 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.316 | -0.101 | 2.58 | 9.48 | 9.94 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -0.316 | -0.101 | 1.42 | 9.48 | 9.94 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -0.316 | -0.101 | 1.42 | 9.48 | 9.94 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.048 | -0.012 | 0.164 | 0.79 | 0.83 |
Dividends per Share |